Moneycontrol
HomeNewsBusinessEconomyPLI scheme could help double workforce requirement in manufacturing sector in FY2021-22
Trending Topics

PLI scheme could help double workforce requirement in manufacturing sector in FY2021-22

In October, the Ministry of Electronics and Information Technology (MeitY) approved 16 eligible applicants under the PLI scheme. The PLI for large scale electronics manufacturing extends an incentive of 4 to 6 percent on incremental sales of goods manufactured in India to the eligible companies, for a period of five years.

November 23, 2020 / 17:23 IST
Story continues below Advertisement

The Production Linked Incentive (PLI) scheme has the potential to create nearly 1.40 crore man-months worth of jobs directly, from the upcoming financial year, as per industry estimates.

Lohit Bhatia, President, Indian Staffing Federation told Moneycontrol, “The PLI scheme has a potential of creating close to 1.40 crore man-months of additional workers. We can say that we are looking to double the workforce engaged in production and manufacturing activities.”

Story continues below Advertisement

“Additionally, the PLI scheme is expected to have a cascading effect, the impact of which will go right up to the MSME (Micro, Small and Medium Enterprises) sector,” Bhatia added. 

With the inclusion of the suppliers and vendors of the manufacturing companies benefitting from the PLI scheme, a total of 4.20 crore man-months of jobs are set to be generated, as per the data by Indian Staffing Federation. 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show